エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/31 | 2,888 | 2,944 | 2,817 | 2,928 | +15 | +0.5% | 40,200 |
2022/03/30 | 2,873 | 2,913 | 2,824 | 2,913 | +128 | +4.6% | 37,600 |
2022/03/29 | 2,657 | 2,802 | 2,656 | 2,785 | +159 | +6.1% | 28,600 |
2022/03/28 | 2,701 | 2,714 | 2,607 | 2,626 | -72 | -2.7% | 22,200 |
2022/03/25 | 2,754 | 2,754 | 2,637 | 2,698 | -6 | -0.2% | 21,800 |
2022/03/24 | 2,573 | 2,704 | 2,570 | 2,704 | +61 | +2.3% | 30,500 |
2022/03/23 | 2,500 | 2,643 | 2,500 | 2,643 | +177 | +7.2% | 38,200 |
2022/03/22 | 2,495 | 2,500 | 2,413 | 2,466 | +21 | +0.9% | 24,000 |
2022/03/18 | 2,409 | 2,485 | 2,392 | 2,445 | +45 | +1.9% | 28,000 |
2022/03/17 | 2,370 | 2,412 | 2,346 | 2,400 | +130 | +5.7% | 22,000 |
2022/03/16 | 2,300 | 2,311 | 2,226 | 2,270 | +30 | +1.3% | 16,800 |
2022/03/15 | 2,208 | 2,286 | 2,190 | 2,240 | +7 | +0.3% | 32,800 |
2022/03/14 | 2,286 | 2,365 | 2,233 | 2,233 | -66 | -2.9% | 41,400 |
2022/03/11 | 2,280 | 2,335 | 2,235 | 2,299 | -8 | -0.3% | 34,200 |
2022/03/10 | 2,251 | 2,307 | 2,233 | 2,307 | +164 | +7.7% | 35,600 |
2022/03/09 | 2,084 | 2,176 | 2,084 | 2,143 | +16 | +0.8% | 32,000 |
2022/03/08 | 2,124 | 2,238 | 2,100 | 2,127 | -47 | -2.2% | 42,200 |
2022/03/07 | 2,109 | 2,197 | 2,081 | 2,174 | +15 | +0.7% | 43,400 |
2022/03/04 | 2,206 | 2,208 | 2,112 | 2,159 | -71 | -3.2% | 44,500 |
2022/03/03 | 2,260 | 2,308 | 2,195 | 2,230 | +1 | ±0% | 21,000 |
2022/03/02 | 2,173 | 2,238 | 2,160 | 2,229 | -19 | -0.8% | 34,200 |
2022/03/01 | 2,155 | 2,259 | 2,154 | 2,248 | +124 | +5.8% | 40,600 |
2022/02/28 | 2,018 | 2,126 | 2,007 | 2,124 | +80 | +3.9% | 43,600 |
2022/02/25 | 1,895 | 2,044 | 1,885 | 2,044 | +212 | +11.6% | 71,000 |
2022/02/24 | 1,887 | 1,950 | 1,806 | 1,832 | -95 | -4.9% | 69,700 |
2022/02/22 | 1,950 | 2,008 | 1,910 | 1,927 | -53 | -2.7% | 39,000 |
2022/02/21 | 1,978 | 1,989 | 1,910 | 1,980 | -28 | -1.4% | 30,100 |
2022/02/18 | 1,942 | 2,020 | 1,888 | 2,008 | +26 | +1.3% | 45,000 |
2022/02/17 | 2,020 | 2,055 | 1,963 | 1,982 | -39 | -1.9% | 43,800 |
2022/02/16 | 2,010 | 2,053 | 1,978 | 2,021 | +51 | +2.6% | 68,100 |
2022/02/15 | 2,012 | 2,046 | 1,953 | 1,970 | -40 | -2% | 55,100 |
2022/02/14 | 2,051 | 2,142 | 2,000 | 2,010 | -432 | -17.7% | 139,400 |
2022/02/10 | 2,435 | 2,478 | 2,379 | 2,442 | +57 | +2.4% | 24,600 |
2022/02/09 | 2,291 | 2,389 | 2,263 | 2,385 | +94 | +4.1% | 16,800 |
2022/02/08 | 2,347 | 2,385 | 2,291 | 2,291 | -16 | -0.7% | 10,900 |
2022/02/07 | 2,384 | 2,404 | 2,290 | 2,307 | -94 | -3.9% | 19,000 |
2022/02/04 | 2,325 | 2,407 | 2,287 | 2,401 | +76 | +3.3% | 13,700 |
2022/02/03 | 2,453 | 2,453 | 2,311 | 2,325 | -128 | -5.2% | 20,100 |
2022/02/02 | 2,368 | 2,460 | 2,368 | 2,453 | +85 | +3.6% | 18,200 |
2022/02/01 | 2,403 | 2,467 | 2,331 | 2,368 | +24 | +1% | 24,600 |
2022/01/31 | 2,228 | 2,396 | 2,228 | 2,344 | +116 | +5.2% | 22,700 |
2022/01/28 | 2,219 | 2,278 | 2,158 | 2,228 | +48 | +2.2% | 67,900 |
2022/01/27 | 2,385 | 2,385 | 2,168 | 2,180 | -184 | -7.8% | 82,400 |
2022/01/26 | 2,352 | 2,423 | 2,305 | 2,364 | -4 | -0.2% | 30,900 |
2022/01/25 | 2,488 | 2,500 | 2,315 | 2,368 | -89 | -3.6% | 42,200 |
2022/01/24 | 2,418 | 2,473 | 2,383 | 2,457 | -11 | -0.4% | 29,600 |
2022/01/21 | 2,383 | 2,474 | 2,350 | 2,468 | +31 | +1.3% | 28,600 |
2022/01/20 | 2,327 | 2,482 | 2,327 | 2,437 | +116 | +5% | 28,500 |
2022/01/19 | 2,391 | 2,445 | 2,301 | 2,321 | -120 | -4.9% | 36,200 |
2022/01/18 | 2,440 | 2,510 | 2,415 | 2,441 | ±0 | ±0% | 21,700 |
651~
700
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム